Cargando…
Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver
Simultaneous resection of synchronous hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) is extremely rare. Case 1 is a 64-year-old woman, who had undergone anterior resection for rectal cancer 3 years earlier was pointed out to have a cystic tumor in the pancreatic tail and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167653/ https://www.ncbi.nlm.nih.gov/pubmed/30283284 http://dx.doi.org/10.1159/000490658 |
_version_ | 1783360242760810496 |
---|---|
author | Taniai, Tomohiko Haruki, Koichiro Shiba, Hiroaki Onda, Shinji Sakamoto, Taro Yanaga, Katsuhiko |
author_facet | Taniai, Tomohiko Haruki, Koichiro Shiba, Hiroaki Onda, Shinji Sakamoto, Taro Yanaga, Katsuhiko |
author_sort | Taniai, Tomohiko |
collection | PubMed |
description | Simultaneous resection of synchronous hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) is extremely rare. Case 1 is a 64-year-old woman, who had undergone anterior resection for rectal cancer 3 years earlier was pointed out to have a cystic tumor in the pancreatic tail and a solitary tumor in the liver. CT revealed a hypovascular tumor in the pancreatic tail and a liver tumor with early enhancement. With a diagnosis of simultaneous HCC and PDAC, she underwent laparotomy, in which intraoperative frozen section examination of the liver was compatible with HCC. Therefore, she underwent hepatic resection as well as distal pancreatectomy and splenectomy. The patient received adjuvant chemotherapy with S-1 and remains well with no evidence of tumor recurrence as of 28 months after resection. Case 2 is a 73-year-old man with sustained viral response to antiviral treatment for hepatitis C virus, who was pointed out to have a tumor in the pancreatic head and a solitary tumor in the liver. Gadoxetic acid-enhanced MRI exhibited enhancement compatible with HCC. With a diagnosis of concomitant HCC and PDAC, surgery was performed. Intraoperative frozen section examination was compatible with HCC, for which a pancreaticoduodenectomy was performed. The patient received adjuvant chemotherapy with S-1 and remains well with no evidence of tumor recurrence as of 16 months after resection. In conclusion, we describe 2 cases of hepato-pancreatectomy for synchronous double primary cancers of the pancreas and the liver, where exclusion of the liver tumor as a metastatic lesion from the pancreatic cancer is important. |
format | Online Article Text |
id | pubmed-6167653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-61676532018-10-03 Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver Taniai, Tomohiko Haruki, Koichiro Shiba, Hiroaki Onda, Shinji Sakamoto, Taro Yanaga, Katsuhiko Case Rep Gastroenterol Case Series Simultaneous resection of synchronous hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) is extremely rare. Case 1 is a 64-year-old woman, who had undergone anterior resection for rectal cancer 3 years earlier was pointed out to have a cystic tumor in the pancreatic tail and a solitary tumor in the liver. CT revealed a hypovascular tumor in the pancreatic tail and a liver tumor with early enhancement. With a diagnosis of simultaneous HCC and PDAC, she underwent laparotomy, in which intraoperative frozen section examination of the liver was compatible with HCC. Therefore, she underwent hepatic resection as well as distal pancreatectomy and splenectomy. The patient received adjuvant chemotherapy with S-1 and remains well with no evidence of tumor recurrence as of 28 months after resection. Case 2 is a 73-year-old man with sustained viral response to antiviral treatment for hepatitis C virus, who was pointed out to have a tumor in the pancreatic head and a solitary tumor in the liver. Gadoxetic acid-enhanced MRI exhibited enhancement compatible with HCC. With a diagnosis of concomitant HCC and PDAC, surgery was performed. Intraoperative frozen section examination was compatible with HCC, for which a pancreaticoduodenectomy was performed. The patient received adjuvant chemotherapy with S-1 and remains well with no evidence of tumor recurrence as of 16 months after resection. In conclusion, we describe 2 cases of hepato-pancreatectomy for synchronous double primary cancers of the pancreas and the liver, where exclusion of the liver tumor as a metastatic lesion from the pancreatic cancer is important. S. Karger AG 2018-08-28 /pmc/articles/PMC6167653/ /pubmed/30283284 http://dx.doi.org/10.1159/000490658 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Series Taniai, Tomohiko Haruki, Koichiro Shiba, Hiroaki Onda, Shinji Sakamoto, Taro Yanaga, Katsuhiko Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver |
title | Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver |
title_full | Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver |
title_fullStr | Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver |
title_full_unstemmed | Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver |
title_short | Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver |
title_sort | simultaneous resection for synchronous double primary cancers of the pancreas and the liver |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167653/ https://www.ncbi.nlm.nih.gov/pubmed/30283284 http://dx.doi.org/10.1159/000490658 |
work_keys_str_mv | AT taniaitomohiko simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver AT harukikoichiro simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver AT shibahiroaki simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver AT ondashinji simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver AT sakamototaro simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver AT yanagakatsuhiko simultaneousresectionforsynchronousdoubleprimarycancersofthepancreasandtheliver |